Glycated hemoglobin as a prognostic risk marker in nondiabetic patients after acute myocardial infarction: what now?
Glycated hemoglobin as a prognostic risk marker in nondiabetic patients after acute myocardial infarction: what now?
复制标题
糖化血红蛋白作为急性心肌梗死后非糖尿病患者的预后风险标志物：现在怎么办？
DOI：
10.1161/circulationaha.111.043877
复制
发表时间：
2011
期刊：
影响因子：
37.8
通讯作者：
Aguilar,David
中科院分区：
文献类型：
--
作者：
Aguilar,David
胰岛素抵抗和糖尿病的流行继续增加，仍然是对全球健康的巨大威胁。据估计，11%的美国成年人患有糖尿病，另有35%的人因空腹血糖或糖化血红蛋白（HbA1c）水平升高而患有前驱糖尿病。1尽管心血管危险因素的管理有所改善，但糖尿病仍使发生多种心血管并发症的风险增加了2倍，这一发现与合并症无关，并且仍然知之甚少。2
The pandemic of insulin resistance and diabetes mellitus continues to increase and remains a tremendous threat to global health. It is estimated that 11% of US adults have diabetes mellitus and another 35% have prediabetes based on elevated fasting glucose or glycohemoglobin (HbA1c) levels. 1 Despite improvements in the management of cardiovascular risk factors, diabetes mellitus continues to confer an 2-fold increased risk for the development of myriad cardiovascular complications, a finding that is independent of comorbid conditions and remains poorly understood. 2
影响因子：
--
作者：
Selvin, E;Coresh, J;Steffes, MW
通讯作者：
Steffes, MW
影响因子：
158.5
作者：
DeFronzo, Ralph A.;Tripathy, Devjit;Reaven, Peter D.
通讯作者：
Reaven, Peter D.
影响因子：
8.2
作者：
Gerstein, H. C.;Islam, S.;Yusuf, S.
通讯作者：
Yusuf, S.